FDA Approved: ACIPHEX — Supplemental Application (Waylis Therapeutics LLC)

View source ↗

Summary

The FDA approved a supplemental application for ACIPHEX (rabeprazole sodium) by Waylis Therapeutics LLC. The snippet does not specify the exact nature of the su…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Erosive Esophagitis
• Gastric Ulcer
• Gastroesophageal Reflux Disease
• Peptic Ulcer Disease

Drugs mentioned

• ACIPHEX (rabeprazole sodium)

Snippet

SUPPL AP for ACIPHEX (RABEPRAZOLE SODIUM)